Literature DB >> 16007074

Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.

Abdolrahman S Nateri1, Bradley Spencer-Dene, Axel Behrens.   

Abstract

The proto-oncoprotein c-Jun is a component of the AP-1 transcription factor, the activity of which is augmented in many tumour types. An important mechanism in the stimulation of AP-1 function is amino-terminal phosphorylation of c-Jun by the c-Jun N-terminal kinases (JNKs). Phosphorylated c-Jun is biologically more active, partially because it acquires the ability to interact with binding partners. Here we show that phosphorylated c-Jun interacts with the HMG-box transcription factor TCF4 to form a ternary complex containing c-Jun, TCF4 and beta-catenin. Chromatin immunoprecipitation assays revealed JNK-dependent c-Jun-TCF4 interaction on the c-jun promoter, and c-Jun and TCF4 cooperatively activated the c-jun promoter in reporter assays in a beta-catenin-dependent manner. In the Apc(Min) mouse model of intestinal cancer, genetic abrogation of c-Jun N-terminal phosphorylation or gut-specific conditional c-jun inactivation reduced tumour number and size and prolonged lifespan. Therefore, the phosphorylation-dependent interaction between c-Jun and TCF4 regulates intestinal tumorigenesis by integrating JNK and APC/beta-catenin, two distinct pathways activated by WNT signalling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007074     DOI: 10.1038/nature03914

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  160 in total

Review 1.  Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.

Authors:  Catherine D Mao; Stephen W Byers
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

2.  Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation.

Authors:  Clare C Davies; Atanu Chakraborty; Filippo Cipriani; Katharina Haigh; Jody J Haigh; Axel Behrens
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

3.  Involvement of JNK in the embryonic development and organogenesis in zebrafish.

Authors:  Yamei Xiao; Yonghua Zhou; Zhen Xiong; Lijun Zou; Minggui Jiang; Zhongwen Luo; Sheng Wen; Wenbin Liu; Shaojun Liu; Wancheng Li
Journal:  Mar Biotechnol (NY)       Date:  2013-07-25       Impact factor: 3.619

4.  The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.

Authors:  Dan Xin; Beatriz E Rendon; Ming Zhao; Millicent Winner; Arlixer McGhee Coleman; Robert A Mitchell
Journal:  Mol Cancer Res       Date:  2010-11-11       Impact factor: 5.852

5.  Loss of JNK2 increases intestinal tumor susceptibility in Apc1638+/- mice with dietary modulation.

Authors:  Xiuli Bi; Nicole M Pohl; Zhinan Yin; Wancai Yang
Journal:  Carcinogenesis       Date:  2010-12-23       Impact factor: 4.944

6.  Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.

Authors:  Kavneet Kaur; Aanchal Kakkar; Anupam Kumar; Suvendu Purkait; Supriya Mallick; Vaishali Suri; Mehar C Sharma; Pramod K Julka; Deepak Gupta; Ashish Suri; Chitra Sarkar
Journal:  J Neurooncol       Date:  2016-08-30       Impact factor: 4.130

7.  ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.

Authors:  E Sánchez-Tilló; O de Barrios; E Valls; D S Darling; A Castells; A Postigo
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

8.  c-Jun N-terminal kinase 1 interacts with and negatively regulates Wnt/beta-catenin signaling through GSK3beta pathway.

Authors:  Dong Hu; Wenfeng Fang; Anjia Han; Lindsay Gallagher; Roger J Davis; Bin Xiong; Wancai Yang
Journal:  Carcinogenesis       Date:  2008-10-24       Impact factor: 4.944

9.  Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction.

Authors:  Chun-Liang Lin; Jeng-Yi Wang; Jih-Yang Ko; Yu-Ting Huang; Yu-Hsia Kuo; Feng-Sheng Wang
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

10.  Oral administration of blueberry inhibits angiogenic tumor growth and enhances survival of mice with endothelial cell neoplasm.

Authors:  Gayle Gordillo; Huiqing Fang; Savita Khanna; Justin Harper; Gary Phillips; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.